Atara Biotherapeutics, Inc. (ATRA) vs LENSAR Inc (LNSR)
A side-by-side comparison of Atara Biotherapeutics, Inc. and LENSAR Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRA
Atara Biotherapeutics, Inc.
$9.52HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
LNSR
LENSAR Inc
$6.69HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — ATRA vs LNSR
growth of $100 · dividends reinvested · last 6yATRA -97.2% (-44.8%/yr)LNSR -25.9% (-4.9%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
ATRA LNSR
ATRA vs LNSR: by the numbers
- •ATRA is the larger company ($86M vs $82M market cap).
- •LNSR is profitable (57.57% net margin) while ATRA runs a net loss (-269.42%).
- •ATRA grew revenue faster over the past five years (56.10% vs 14.67% CAGR).
Metrics side by side
Valuation
| Metric | ATRA | LNSR |
|---|---|---|
| P/S ratio | 13.85 | 1.36 |
| P/B ratio | N/A | 5.51 |
Profitability
| Metric | ATRA | LNSR |
|---|---|---|
| Gross margin | 82.44% | 47.96% |
| Operating margin | 29.69% | -42.06% |
| Net margin | -269.42% | 57.57% |
| ROE | N/A | 232.78% |
| ROIC | -100.35% | -16.28% |
Growth (annualized)
| Metric | ATRA | LNSR |
|---|---|---|
| Revenue CAGR (5Y) | 56.10% | 14.67% |
| Total return CAGR (5Y) | -53.60% | -3.18% |
Frequently asked
- Which has grown faster, ATRA or LNSR?
- Over the past five years, ATRA grew revenue faster — ATRA at a 56.10% CAGR versus LNSR at 14.67%.
- Is ATRA or LNSR more profitable?
- LNSR runs the higher net margin — ATRA at -269.42% versus LNSR at 57.57%.
- How have ATRA and LNSR total returns compared?
- Over the past 5 years, ATRA delivered -53.60% and LNSR delivered -3.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Atara Biotherapeutics ROELENSAR ROEAtara Biotherapeutics operating marginLENSAR operating marginAtara Biotherapeutics revenue growthLENSAR revenue growthAtara Biotherapeutics free cash flowLENSAR free cash flow
Atara Biotherapeutics & LENSAR appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.